IMRES Manuscript Template General

You might also like

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 10

Title

- Please capitalize only the first letter of the first word, and also capitalize the first letters of proper nouns.
- Please make your title clear and concise, yet descriptive of your study (intervention, disease or participants,
study design, etc.).

First Author, a, 1 Second Author, b, 1 Third Author, b Corresponding Author c, *

a
First affiliation department, Institution, City, Country
b
Second affiliation department, Institution, City, Country
c
Third affiliation department, Institution, City, Country

1
The authors contributed equally to this work as co-first authors. (if co-first authors need to be indicated)

- Please provide all authors’ full names, in order of first name, middle name, and last name.
- Please do NOT provide academic degrees such as PhD.
- Please do NOT put full address or postal code (zip code) for affiliation.
- If there are co-first authors, use superscript number 1. Only up to 2 co-first authors are allowed.
- Please indicate corresponding author using asterisk mark. If there are co-corresponding authors, use the single
asterisk mark(*) for both. Only up to 2 co-corresponding authors are allowed.

* Corresponding author at:

Affiliation, Address, City and Postal code, Country

E-mail address: ***@***.***

- For co-corresponding authors, place the corresponding author first/middle name initial(s) with last name, after
each postal address and email address.

* Corresponding authors at:


First corresponding author affiliation, Full address, City, State and Postal code, Country (First/middle name
initials. Last name);
Second corresponding author affiliation, Full address, City, State and Postal code, Country (First /middle name
initials. Last name).

Email addresses: ***@***.*** (First/middle name initials. Last name); ***@***.*** (First/middle name
initials. Last name).

ORCID iD:
First Author’s Name: 0000-0000-0000-0000

Second Author’s Name: 0000-0000-0000-0000

Third Author’s Name: 0000-0000-0000-0000

Corresponding Author’s Name: 0000-0000-0000-0000

- ORCID is mandatory for all authors. If any of the authors do not have it, please visit ORCID website at
https://orcid.org

- IMR requires certain types of studies to follow relevant reporting guidelines: https://www.equator-
network.org/.
If applicable, the relevant checklist must be submitted during submission and the checklist will be published as a
supplement once the paper is accepted.
- Highlights and list of abbreviations are NOT needed.
- If a graphical abstract is available, please submit it. It will be considered for promoting the article on the
journal’s social network services once accepted.

-2-
Abstract

- Please limit abstract to 250 words. (Try to keep it within 200 words.)

Background:

Methods:

Results:

Conclusion:

Trial registration/Protocol registration: Name of registry and registration number.

- For clinical trials, please add name of registry (e.g. ClinicalTrials.gov, WHO ICTRP, ISRCTN, CRIS, CTRI, etc.) and
clinical trial registration number at the end of the abstract.
- For systematic reviews, please add name of registry (e.g. PROSPERO) and protocol registration number at the
end of the abstract.
- Other international registration is acceptable.

Keywords:

- Please add 3-5 keywords in alphabet order.

-3-
- Section headings should be numbered.
- For editorial materials like commentary, section headings are not needed.
- Superscript numbers should be used for citations.
- EndNote style for the journal can be downloaded at: https://endnote.com/style_download/integrative-
medicine-research/

1. Introduction

- Please type your introduction, including background, description of condition, description of intervention,
rationale, and aim of the study.

2. Methods

2.1

2.2

2.3

3. Results

3.1

3.2

3.3

4. Discussion

- Please discuss your findings and support your statements using previous studies.
- Clinical implications and limitations should be discussed here.
- Conclusion should be merged into this section.
- If needed, subheadings can also be used. 4.1, 4.2, etc.

-4-
Acknowledgements (if any)
The authors would like to thank ***, (affiliation), for ***.

- Acknowledgements are optional.


If there is no one to acknowledge then please delete this section.

Author contributions
Conceptualization: ***. Methodology: ***. Software: ***. Validation: ***. Formal analysis: ***,
***. Investigation: ***, ***, ***. Resources: ***. Data curation: ***. Writing – Original Draft: ***,
***. Writing – Review & Editing: ***, ***, ***. Visualization: ***. Supervision: ***. Project
administration: ***. Funding acquisition: ***.

- For each Contributor Roles Taxonomy (CRediT) where applicable, please add author initials.
- If there is any overlap of author initials, please spell out the last name or the full name.
- Please refer to CRediT author statement taxonomy below:

Term Definition
Conceptualization Ideas; formulation or evolution of overarching research goals and aims
Methodology Development or design of methodology; creation of models
Programming, software development; designing computer programs;
Software implementation of the computer code and supporting algorithms; testing of
existing code components
Verification, whether as a part of the activity or separate, of the overall
Validation
replication/ reproducibility of results/experiments and other research outputs
Application of statistical, mathematical, computational, or other formal
Formal analysis
techniques to analyze or synthesize study data
Conducting a research and investigation process, specifically performing the
Investigation
experiments, or data/evidence collection
Provision of study materials, reagents, materials, patients, laboratory
Resources samples, animals, instrumentation, computing resources, or other analysis
tools
Management activities to annotate (produce metadata), scrub data and
Data Curation maintain research data (including software code, where it is necessary for
interpreting the data itself) for initial use and later reuse
Writing - Original Preparation, creation and/or presentation of the published work, specifically
Draft writing the initial draft (including substantive translation)
Preparation, creation and/or presentation of the published work by those
Writing - Review
from the original research group, specifically critical review, commentary or
& Editing
revision – including pre-or postpublication stages
Preparation, creation and/or presentation of the published work, specifically
Visualization
visualization/ data presentation

-5-
Oversight and leadership responsibility for the research activity planning and
Supervision
execution, including mentorship external to the core team
Project Management and coordination responsibility for the research activity
administration planning and execution
Funding
Acquisition of the financial support for the project leading to this publication
acquisition

Conflict of interest
The authors declare that they have no conflicts of interest.

- If you have any (potential) conflict of interest, please state it here.


- If you are an editorial board member, please state it in this section. For example, “** is an
editorial board member of this journal but editorial board member status had no bearing on
editorial consideration. The authors have no other conflict of interest to declare.”

Funding
This research was supported by ******.

- If funding was received for the study, please indicate the funding body and grant number.
- If none was received, please state “None” or “No funding was received for this work.”

Ethical statement
(For human research)
This research was reviewed and approved by the institutional review board of *** University Hospital
(registration number *****). Informed consent was obtained from all participants.
(For animal research)
This research was approved by the institutional animal care and use committee (*****).

- For other studies not involving human or animal researches, please state “No ethical approval
was required as this study did not involve human participants or laboratory animals.”

Data availability
The data that support the findings of this study are ***.

- Please refer to some examples of data availability statement.

-6-
 The data that support the findings of this study are available from the corresponding author
upon reasonable request.
 The data that support the findings of this study are openly available in [repository name] at
http://doi.org/***, reference number ***.
 The data that support the findings of this study are available within the article [and/or its
supplementary material].
 The data are not publicly available due to ***.
 Data sharing is not applicable to this article as no new data were created or analyzed in
this study.

-7-
References

1. Bisdas T, Pichlmaier M, Wilhelmi M, Bisdas S, Haverich A, Teebken O. Effects of the ABO-

mismatch between donor and recipient of cryopreserved arterial homografts. Int Angiol 2011;

30:247-55.

2.

3.

- For references, they are listed in the order of appearance.


- IMR uses superscript numbers for in-text citations.
- If authors use EndNote, the journal’s style can be downloaded at:
https://endnote.com/style_download/integrative-medicine-research/

- List author names in the order of last name, space, first/middle name initial(s).
- If they are more than 6, list 3 authors and add “et al.”

- Please refer to the journal’s Guide for Authors for any other information not included in this template.
https://www.elsevier.com/journals/integrative-medicine-research/2213-4220/guide-for-authors

-8-
- Please add one table per page.
- Abbreviations should be listed in the alphabet order. Abbreviation should be followed by a comma, then full
term, separated by semi colon for each abbreviation (Ex. MO, month; NA, not applicable; TCM, traditional
Chinese medicine.).
- For supplementary tables, attach them as a separate file.

Table 1

Table title.

Stub heading Column spanner Column spanner

Column Column Column Column


heading heading heading heading
Table spanner ------------------------------------

AAA 1

Bbb

Ccc

DDD

EEE

AAA, a— a— a—; Bbb, b— b— b—; Ccc, c— c— c—; DDD, d— d— d—; EEE, e— e— e—.

-9-
- Add figure legends at the end of the manuscript file.
- Please attach high resolution figure(s) as separate file(s).
- For figures prepared by Microsoft Word or PowerPoint, please provide the figure in .docx or .pptx format.

Figure legends

Fig. 1. Figure title.

Figure note.

- 10 -

You might also like